Up-front tandem high-dose chemotherapy compared with standard chemotherapy with doxorubicin and paclitaxel in metastatic breast cancer: results of a randomized trial.
about
Taxane-containing regimens for metastatic breast cancerHigh dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with metastatic breast cancerBreast cancer (metastatic).Long-Term Outcome of Inflammatory Breast Cancer Compared to Non-Inflammatory Breast Cancer in the Setting of High-Dose Chemotherapy with Autologous Hematopoietic Cell Transplantation.Filling in the gaps: reporting of concurrent supportive care therapies in breast cancer chemotherapy trials.Long-term outcome of patients with metastatic breast cancer treated with high-dose chemotherapy and transplantation of purified autologous hematopoietic stem cellsHigh-dose chemotherapy with autologous hematopoietic stem-cell transplantation in metastatic breast cancer: overview of six randomized trials.Long-term survival in patients with metastatic breast cancer receiving intensified chemotherapy and stem cell rescue: data from the Italian registry.Estrogen receptor-alpha 36 mediates the anti-apoptotic effect of estradiol in triple negative breast cancer cells via a membrane-associated mechanism.International guidelines for management of metastatic breast cancer: can metastatic breast cancer be cured?Role of stem cells in cancer therapy and cancer stem cells: a review.Long-term survival after high-dose chemotherapy followed by peripheral stem cell rescue for high-risk, locally advanced/inflammatory, and metastatic breast cancer.Cardiac toxicity of trastuzumab in metastatic breast cancer patients previously treated with high-dose chemotherapy: a retrospective studyNab-paclitaxel for breast cancer: a new formulation with an improved safety profile and greater efficacy.Relationship between effects on time-to-disease progression and overall survival in studies of metastatic breast cancer.Improvement of survival and prospect of cure in patients with metastatic breast cancer.Critical issues on high-dose chemotherapy with autologous hematopoietic progenitor cell transplantation in breast cancer patients.Treating breast cancer with cell-based approaches: an overview.Pilot study of MDR1 gene transfer into hematopoietic stem cells and chemoprotection in metastatic breast cancer patients.A retrospective evaluation of second-line chemotherapy response in hormone-refractory prostate carcinoma: second line taxane-based therapy after first-line epothilone-B analog ixabepilone (BMS-247550) therapy.Highly favorable outcome in BRCA-mutated metastatic breast cancer patients receiving high-dose chemotherapy and autologous hematopoietic stem cell transplantation.Chemotherapy protocols and incidence of oral mucositis. An integrative review.Breast cancer (metastatic)Is high-dose chemotherapy with autologous hematopoietic stem cell transplantation in breast cancer patients a done deal?
P2860
Q24187214-90317952-191B-4B5B-99C2-229C9E3CAF23Q24246595-031E25CB-9E3E-4EBB-B46F-1EAF4998470BQ33448016-0D75564B-97D7-452D-9990-A4BB4A06E435Q33702336-72E8A2BF-E419-4B69-938C-1F9A8C48036CQ33785011-C49B0D2C-78EE-4EFF-8507-4DBD2C68CC87Q33959862-AAD2DE77-C9BD-4E42-ACCB-9709404E970BQ34201582-67EA8512-52C2-41A4-B247-A3F383EEFC04Q34366379-2D3F9DE7-B74E-4049-A437-7EEF02DAC451Q34976544-950755C5-F866-46C6-900D-E3F26FA052C1Q35820247-76717C23-99E8-46E8-91CD-409B5F233CC3Q35846826-18EBD0F6-AEF1-4E5B-9638-04DAF5AFF63FQ36528656-52A84F40-5ADE-440B-8955-5053B4D6E603Q36613992-D04738AB-73FC-494C-9EF3-5684A5E051E1Q36879127-8894AFE2-409F-499A-92E9-058EEC2EDE82Q36977501-F8D82629-2287-4B4B-81FC-4104C028FF95Q37386277-B1641D9A-DEC4-4B4E-898F-53F88F8FC5CBQ38040419-86630AF1-C050-49A7-A8A9-EBF927BBB049Q39448180-EC051CCF-C17E-4F5A-BEDE-263E7D3D7D1BQ45870042-D3A01D8D-A538-4C63-967F-D2A78DDD38B1Q46013031-4FD5A7E7-93CC-4271-AEE9-A0D00BA3FF1CQ50912716-F93729BA-1D09-4FBB-A1E2-4E84FA2CF19EQ55024194-BDD3BB54-A968-47A4-A2C7-6A3808DF187CQ57139202-23543441-56FC-4CDC-AF72-236BE3E54F47Q57139697-9C2C1D32-8E80-4AFB-9260-A2DC1D02DCDD
P2860
Up-front tandem high-dose chemotherapy compared with standard chemotherapy with doxorubicin and paclitaxel in metastatic breast cancer: results of a randomized trial.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Up-front tandem high-dose chem ...... results of a randomized trial.
@en
Up-front tandem high-dose chem ...... results of a randomized trial.
@nl
type
label
Up-front tandem high-dose chem ...... results of a randomized trial.
@en
Up-front tandem high-dose chem ...... results of a randomized trial.
@nl
prefLabel
Up-front tandem high-dose chem ...... results of a randomized trial.
@en
Up-front tandem high-dose chem ...... results of a randomized trial.
@nl
P2093
P356
P1476
Up-front tandem high-dose chem ...... results of a randomized trial
@en
P2093
Gerdt Huebner
Hubert Hausmaninger
Kurt Possinger
Peter Schmid
Thorsten Nitsch
Volker Heilmann
Walter Schippinger
Wolfgang Schultze
P304
P356
10.1200/JCO.2005.06.072
P407
P577
2005-01-01T00:00:00Z